Clinical Trial Update: Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of the experimental compound DITPA was terminated in adults with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• DITPA (3,5-diiodothyropropionic acid) (3,5-diiodothyropropionic acid)

Snippet

Sponsor: Johns Hopkins University | Conditions: Hypercholesterolemia | Phase 1, Phase 2 | Status: TERMINATED